Tyra Biosciences, Inc. (TYRA)
35.21
-1.83
(-4.94%)
USD |
NASDAQ |
May 18, 13:16
Tyra Biosciences Research and Development Expense (Quarterly) : 33.33M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 60.41M |
| Relay Therapeutics, Inc. | 70.56M |
| Tango Therapeutics, Inc. | 33.07M |
| Entrada Therapeutics, Inc. | 32.25M |
| BioMarin Pharmaceutical, Inc. | 178.80M |